News Focus
News Focus
Followers 11
Posts 141
Boards Moderated 0
Alias Born 02/20/2024

Re: GoodGuyBill post# 766913

Saturday, 05/10/2025 1:04:50 PM

Saturday, May 10, 2025 1:04:50 PM

Post# of 827918
Doc Logic makes a lot of plausible reasoning what and why this IFR for all type of cancers while GBM n rGBM is approve and cover by NHS funding. I believe NHS will try to stream line DCVAX-l approval process for all types of tumor cancers once they confirmed efficacy of DCVAX-l through rolling review of RWE with IFR means. I am very please with this revelation. I remember LG once said DCVX-l being kind of like biological AI which will be essential for all tumor target immunotherapy, ICI, Cat-T...etc. This synergistic combo treatments will accelerate the adoption of DCVAX-l like NVIDA coming out of nowhere becoming a Trillion $ company overnight, but they been a suffering small tech company for over 10 years just like NWBO. I see the resemblance of the two company with the paradigm shifting compounds, one is for medical and the other is GPU. I believe our time is near ! Hang in there for a little longer. LOL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News